Prolactin delays hair regrowth in mice by Craven, A.J. et al.
415Prolactin delays hair regrowth in miceA J Craven, A J Nixon, M G Ashby, C J Ormandy1, K Blazek1, R J Wilkins2 and A J Pearson
AgResearch Ruakura, Private Bag 3123, Hamilton 2020, New Zealand
1Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales, 2010 Sydney, Australia
2University of Waikato, Hamilton 2020, New Zealand
(Requests for offprints should be addressed to A J Craven; Email: tony.craven@agresearch.co.nz)AbstractMammalian hair growth is cyclic, with hair-producing
follicles alternating between active (anagen) and quiescent
(telogen) phases. The timing of hair cycles is advanced in
prolactin receptor (PRLR) knockout mice, suggesting that
prolactin has a role in regulating follicle cycling. In this study,
the relationship between profiles of circulating prolactin and
the first post-natal hair growth cycle was examined in female
Balb/c mice. Prolactin was found to increase at 3 weeks of
age, prior to the onset of anagen 1 week later. Expression of
PRLR mRNA in skin increased fourfold during early
anagen. This was followed by upregulation of prolactin
mRNA, also expressed in the skin. Pharmacological
suppression of pituitary prolactin advanced dorsal hair growthJournal of Endocrinology (2006) 191, 415–425
0022–0795/06/0191–415 q 2006 Society for Endocrinology Printed in Greatby 3.5 days. Normal hair cycling was restored by replacement
with exogenous prolactin for 3 days. Increasing the duration
of prolactin treatment further retarded entry into anagen.
However, prolactin treatments, which began after follicles had
entered anagen at 26 days of age, did not alter the subsequent
progression of the hair cycle. Skin from PRLR-deficient mice
grafted onto endocrine-normal hosts underwent more rapid
hair cycling than comparable wild-type grafts, with reduced
duration of the telogen phase. These experiments demon-
strate that prolactin regulates the timing of hair growth cycles
in mice via a direct effect on the skin, rather than solely via the
modulation of other endocrine factors.
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Hair growth in mammals is not continuous. Instead, hair
follicles cycle through successive phases of active hair growth
(anagen), involution (catagen) and quiescence (telogen)
(Muller-Rover et al. 2001). The reactivation of follicles to
start a new anagen phase is characterised by the reinitiation of
cell proliferation in the secondary hair germ, regeneration of
the lower half of the follicle and growth of a new hair. In
mice, successive generations of hairs are held in the follicle for
some time before the older shafts are shed (exogen) (Milner
et al. 2002). Also in mice, hair follicle cycling is synchronised,
with waves of hair regrowth commencing in the axillae and
progressing ventro-dorsally before reaching the head and tail.
The timing of these synchronised cycles is age-related, but
varies with sex and strain (Muller-Rover et al. 2001).
Hair follicle cycling is influenced by a variety of hormones
(Ebling et al. 1991, Alonso & Rosenfield 2003), including the
pituitary hormone prolactin. Prolactin receptors (PRLR)
have been localised to hair follicles (Craven et al. 2001) and
expression of mRNAs encoding one long (PRLRL) and two
short forms of the receptor (PRLRS2 and PRLRS3) have
been demonstrated in murine skin. Furthermore, the
concentration of these receptors varies with follicular activity
(Foitzik et al. 2003). PRLR knockout mice grow slightly
longer hair and moult at a younger age than wild-typelittermates, indicating that prolactin signalling is involved in
the timing of progression through the hair cycle phases
(Craven et al. 2001). However, the secretion of other
hormones, including oestrogen, progesterone and parathyroid
hormone (PTH), is xalso altered in PRLR knockout mice
(Bole-Feysot et al. 1998, Clement-Lacroix et al. 1999).
Oestrogen (Oh & Smart 1996, Chanda et al. 2000) and PTH
(Schilli et al. 1997) have been implicated previously in hair
cycle regulation. Thus, it remains unclear whether the
advanced hair cycle phenotype of PRLR knockout mice is
mediated directly by the loss of prolactin signalling within hair
follicles or indirectly by perturbation of other hormones.
Few studies have directly assessed the effect of exogenous
prolactin on hair growth. Organ cultured hair follicles
spontaneously enter a catagen-like state, and this process is
accelerated by added prolactin (Foitzik et al. 2003). However,
only in vivomodels are presently capable of representing other
phases of the hair cycle. Mohn (1958) reported that both
spontaneous and plucking-induced follicle growth was
unchanged following i.m. injections of prolactin to rats.
Similar observations had been made following injections of
crude prolactin extracted from pig and ox pituitaries
(Emmens 1942). Conversely, in a number of other species,
hair follicle cycling is governed by seasonal changes to
produce a summer and winter moult, and prolactin has been
implicated as the principal endocrine regulator of this processDOI: 10.1677/joe.1.06685
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Pearson et al. 1996, Thompson et al. 1997). In recent years, it
has become apparent that the method of prolactin adminis-
tration and the resulting hormone profile are critical in
determining the physiological response of hair follicles
(McCloghry et al. 1993, Soboleva et al. 2005). The time at
which prolactin is administered is also important, suggesting
that follicles may be sensitive to prolactin at only some phases
of the growth cycle. Furthermore, prolactin itself is expressed
in the skin and regulated during the follicle growth cycle
(Foitzik et al. 2003). Both locally produced and systemic
prolactin will contribute to the concentration of prolactin to
which receptors are exposed.
In this study, we aimed to elucidate the influence of
prolactin on the timing of follicle cycle phases in mice. First,
we characterised prolactin signalling activity in the skin of
Balb/c mice, as indicated by plasma prolactin concentrations,
and expression of PRLR variants and prolactin mRNA in the
skin leading up to the growth of the second generation of coat
hairs. Secondly, pituitary prolactin secretion was suppressed
with bromocriptine (BRC), and exogenous prolactin
administered to regulate profiles of circulating prolactin.
These treatments altered follicle growth cycles and identified
a period of prolactin responsiveness during the telogen phase.
Thirdly, we established that prolactin exerts an effect directly
on the skin. Mouse skin lacking PRLRs was grafted onto
mice with normal hormone levels. Accelerated follicle
cycling was seen in transplanted skin, consistent with the
phenotype of the unoperated PRLR knockout. This result
demonstrates that prolactin directly affects hair cycling
mechanisms within the skin.Materials and Methods
Experimental animals
Inbred female Balb/c mice and PRLR knockout mice
(Ormandy et al. 1997) were housed at the Ruakura Small
Animal Colony, Hamilton, New Zealand and fed a diet of
standard mouse pellets and fresh tap water available ad libitum.
They were maintained at a constant temperature of 22 8C
under a photoperiod regime of 14 light:10 darkness. Mice
were housed in family groups until the progeny were weaned
at 21–22 days of age into groups of 4–6 mice. The
experimental procedures were carried out with the approval
of the Ruakura Animal Ethics Committee in accordance with
the New Zealand Animal Welfare Act (1998).Profiles of circulating prolactin and PRLR mRNA in skin
Concentrations of prolactin in blood plasma and of mRNA
encoding PRLR and prolactin in dorsal skin were determined
in 54 untreated Balb/cmice of post-natal ages varying between
15 and 39 days. At 3-day intervals, groups of four mice were
anaesthetised with CO2 and their blood was sampled by heartJournal of Endocrinology (2006) 191, 415–425puncture just prior to euthanasia by cervical dislocation. This
blood was collected into EDTA-containing syringes and
centrifuged to separate plasma, which was then stored frozen
(K20 8C). Dorsal and axillary skin was fixed in phosphate-
buffered 10% formalin for histological assessment of hair
follicle growth stage (Nixon 1993). Additional dorsal skin from
each animal was snap frozen in liquid nitrogen for measure-
ment of prolactin and PRLR mRNA by quantitative PCR.Hormone manipulations
Circulating prolactin was pharmacologically manipulated in
the period preceding and during the growth of the second
generation of hair (G2). A group of mice receiving no
hormonal treatment (control; nZ8) was compared with
groups of mice whose endogenous pituitary prolactin was
suppressed using s.c. pellets releasing 250 mg/day of bromo-
criptine mesylate for up to 60 days (Innovative Research of
America Inc., Sarasota, FL, USA). These BRC implants were
surgically inserted at 15 days of age (nZ6) or 22 days of
age (nZ4).
Ovine prolactin (500 mg/day) dissolved in sodium
bicarbonate buffer (0.2 M; pH 9) was administered via
osmotic mini-pumps (Alzet Model 1003D, 1001 or 1002;
Alza Corporation, Palo Alto, CA, USA) to groups of BRC-
treated mice (nZ2–4 per group). The prolactin adminis-
tration commenced at 18, 22 or 26 days of age and lasted for 3
or 14 days after which time osmotic pumps were removed.
The BRC implants remained in place for the duration of the
experiment. At the end of each treatment period, the osmotic
pumps were removed and a blood sample was collected from
the tail. Following completion of hair regrowth, blood was
collected from all animals.
Three further mice received domperidone (Sigma
Chemical Co.) via an osmotic pump (1.8 mg/kg per day;
dissolved in polyethylene glycol 400 at a concentration of
20 mg/ml), to induce a sustained increase in endogenous
pituitary prolactin secretion. The mice received domperidone
from 18 to 30 days of age and were compared with three
untreated littermates.Assessment of hair growth
To monitor hair growth patterns, the coats of all mice in the
hormone manipulation experiments were dyed black at
22–26 days of age, when all hair follicles were in telogen
(Craven et al. 2001). Subsequent pelage growth was
ascertained by daily visual examination for the presence of
new, unstained hairs. Records were made of the age at which
hair first emerged from axillary skin (where the wave of new
hair growth across the body commences) and dorsal skin (a
site commonly reported in other studies). To assess whether
the age of weaning influenced hair cycling, comparisons in
hair regrowth were also made between untreated siblings
weaned at 18 or 24 days of age (nZ3 per group).www.endocrinology-journals.org
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untreated Balb/c mice was determined by histomorphology
(Nixon 1993, Muller-Rover et al. 2001). Skin sections were
stained by the Sacpic method (Nixon 1993), and at least 30
longitudinally sectioned follicles were assessed from each of
threemice for each age from24 to 39 days. To establish precisely
the time at which cell proliferation within the follicle bulb
commences, proliferating cell nuclear antigen (PCNA) immu-
nohistochemistrywas performedon sections from four mice per
day of age (from days 18–24 for axillary skin; days 25–30 for
dorsal skin). Sections of formalin-fixed skin tissue were washed
in citrate buffer (pH6.0; 10 min), andblocked inPBS/4%BSA/
Tween for 2 h prior to overnight incubation with monoclonal
anti-PCNA antibody (Clone PC10; Dako Corporation,
Carpinteria, CA, USA.) diluted in the ratio of 1/500 in
antibody diluent (Dako Corporation). After three washes with
PBS, these sections were incubated for 1 h with streptavidin–
horseradish peroxidase conjugated goat anti-mouse IgG (Dako
Corporation) diluted in the ratio of 1:100 in antibody diluent.
After further PBS washes, sites of antibody binding were
visualised with diaminobenzidine (Sigma Chemical Co.)
intensified with H2O2 and NiCl2 solution. Follicles exhibiting
more than three PCNA positive cells per section in the bulb
epithelium were considered to have entered anagen.
Follicles were categorised as either telogen (short follicles
with no PCNA staining), anagen I (short follicles and PCNA
positive), anagen II (enlarged bulb starting to form a
proliferating germinal matrix), anagen III (formation of red-
staining inner root sheath and hair cone), anagen IV–V
(formation of picrophilic keratinised hair shaft) or anagen VI
where the new hair tip has emerged from the epidermis
(Nixon 1993, Parry et al. 1995).Radioimmunoassays
Murine prolactin was assayed using rabbit antiserum to
murine prolactin (National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK) mouse prolactin
RIA kit; reagents AFP-6476C; AFP-10777D and AFP-
131078; Torrance, CA, USA). Murine prolactin was
iodinated by the iodogen technique (Pierce, Rockford, IL,
USA), using [125I]iodide (New England Nuclear, Wilmington,
DE, USA). The assay method was essentially as prescribed for
the NIDDK reagents. The separation of the antibody-bound
labelwas by secondary antibody precipitationusing excess sheep
anti-rabbit serum (generated at AgResearch, Hamilton, New
Zealand). Sensitivity using murine prolactin standards was
1 ng/ml. Intra-assay coefficient of variation was 13.4%.
Ovine prolactin was assayed using an ovine prolactin assay
(NIDDK ovine prolactin RIA kit) (Nixon et al. 1993).
Sensitivity using ovine prolactin standards was 0.6 ng/ml.
Intra-assay coefficient of variation at 90 ng/ml was 13.7%.
Cross-reactivity between murine and ovine prolactin was
low; using the ovine RIA,!1 ng/ml was measured in mouse
plasma containing 30 ng/ml murine prolactin or in standard
solutions of 100 ng/ml murine prolactin.www.endocrinology-journals.orgPRLR and prolactin gene expression
Total RNA was extracted using TRIzol (Invitrogen
Corporation), and DNA was removed using RNase-free
DNase I (DNA-free Kit, Ambion, Austin, TX, USA). First,
strand cDNA was generated by reverse transcription (RT)
with random hexamer primers, using the Superscript II
Preamplification System (Invitrogen) according to the
manufacturer’s instructions.
Real-time PCR was carried out using TaqMan (PRLRL,
prolactin and 18S rRNA) or SYBR Green (PRLRS2 and
PRLRS3) reaction mixes and the ABI PRISM 7900HT
Sequence System and Sequence Detection System 1.6 software
(Applied Biosystems, Foster City, CA, USA). Primers and
probes used were as previously reported (Craven et al. 2001)
with the exception of a more efficient PRLRL reverse
primer (50-CTCGTCCTCATTGTCATCCACTT-30). PCR
reactions using 0.25 ml of the RT reaction product were
performed in triplicate, with results compared with a standard
curve. The expression of 18S rRNAwas used as internal control
according to the manufacturer’s guidelines (Eukaryotic 18S
rRNA PDAR, Applied Biosystems). Levels of mRNA are
reported relative to the overall experimental mean for each
analysed gene.Grafting PRLR knockout skin onto scid host mice
Skin for grafting was obtained from four 24-day old
homozygous PRLR knockout mice on a 129Sv background
strain (Ormandy et al. 1997, Craven et al. 2001), and from
four littermates or closely related mice that were wild type for
PRLR. Explants of shaved scapular skin (2!10 mm) were
prepared in Dulbecco’s modified Eagle’s medium (DMEM)
with 10% foetal calf serum and grafted onto 5-week old
NOD-scid host mice of corresponding sex. Ten host mice
each carried two grafts on their scapular regions, one of each
donor genotype. The grafts were sutured and covered with
bandages for 14 days. Hair growth began in some grafts at
17 days after surgery. Pigmented hairs growing from donor
skin contrasted with the white coats of the host mice,
allowing new hair growth in the grafts to be seen. The graft
sites were clipped to skin level (!0.5 mm) during the
growing phase at 7-day intervals (males) or 10–11-day
intervals (females), or as necessary to permit measurement
of growth increments. The lengths of dark hairs arising from
the two graft sites, and from the surrounding host skin, were
recorded at 2–3-day intervals until 89 days after surgery, and
the durations of hair growth from PRLR knockout and wild-
type grafts were compared.Statistical analysis
Prolactin RIA, PRLR and prolactin mRNA quantitative
PCR and hair growth observational data were compared by
pairwise Student’s t-tests or one-way ANOVA. The data are
presented as group means and S.E.M.Journal of Endocrinology (2006) 191, 415–425
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Hair cycling, plasma prolactin and gene expression in untreated
Balb/c mice
The timing of progression through the hair cycle phases was
determined in unmanipulated wild-type Balb/c mice. Histo-
logical analysis showed that the first anagen terminated at
17–19 days in the dorsal skin. Following a brief telogen phase,
the second anagen began with cell division in the hair bulb
(anagen I), initially in the axilla. In this region, 45% of folliclesFigure 1 Histological characterisation of the first
skin of untreated female Balb/c mice are shown.
hair follicles: (a) no PCNA is detected in a lower t
of anagen is characterised by presence of PCNA
age), (c) proliferating cells of the germinal epithe
of age), (d) anagen III follicle (33 days of age), (e
indicate PCNA localisation in nuclei. BarsZ50
showing percentage of dorsal hair follicles in va
the mean proportions of follicles in each stage, o
each of three mice per time point. Error bars indic
immunohistochemical labelling within hair germ
hair is first observed emerging through the skin s
Journal of Endocrinology (2006) 191, 415–425exhibited increased PCNA immunostaining in hair bulb
epithelial cells (O3 cells per section) at 22 days of age. On the
dorsum, 36% of follicles were PCNA positive at day 26, bulb
enlargement and structural reorganisation (anagen II) was first
observed at 29 days of age, and predominated at 32 days
(Fig. 1A). Thereafter, follicles progressed through anagen III
(33 days) and anagen IV (34–35 days). In live animals, the mean
age at which new hair was first observed emerging from the
dorsal skin (anagenVI) was day 36G0.2, although some anagen
III–V follicles persisted until 38 days of age (Fig. 1B).hair replacement cycle. Results for the dorsal
(A) PCNA immunolocalisation in
elogen follicle (26 days of age), (b) induction
in the hair germ during anagen I (27 days of
lium in an anagen II follicle (29 days
) anagen IV follicle (33 days of age). Arrows
mm (B) Summary of histological assessment
rious stages of the hair cycle. Data represent
btained by assessingO30 follicles from
ate S.E.M.C Indicates mean age when PCNA
first occurs and * indicates mean age when
urface.
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passing through this follicle growth cycle. Mean prolactin
concentration in untreated females was 17G10 ng/ml at 15–
18 days of age. Prolactin concentration then increased, rapidly
at first and then more slowly to 76G20 ng/ml at 39 days of
age (P!0.01; Fig. 2A). Thus, changes in circulating prolactin
preceded changes in hair cycle phase.
The expression of PRLR and prolactin in skin also
changed during the follicle cycling period. Expression in
dorsal skin of three isoforms of PRLR was assessed using real
time PCR (Fig. 2B). Levels of PRLRL mRNA were low
throughout the telogen period preceding the first hair
replacement cycle. At 33 days of age, expression began
increasing to reach maximal levels during anagen (36–39
days). Similar expression profiles of PRLRS2 and PRLRS3
mRNA were found, with levels increasing during early
anagen. Compared with the PRLRL isoform, 3–4 moreFigure 2 Characterisation of prolactin sign
replacement cycle. Results for untreated femal
prolactin concentrations were measured by rad
mRNA encoding PRLR isoforms and prolactin
time PCR. Expression levels are normalised to
indicate S.E.M. of four animals per time point.
www.endocrinology-journals.orgPCR cycles were required to amplify the truncated receptor
isoforms, suggesting that they are expressed at lower levels
in skin. Expression of prolactin mRNA in the skin was
similarly depressed during telogen and then increased until
late anagen.Plasma prolactin and pelage replacement in prolactin-manipulated
mice
To directly determine the effect of prolactin on follicle
cycling, endogenous prolactin was suppressed with BRC and
replaced with exogenous prolactin administered at different
ages. BRC suppressed circulating prolactin in implanted mice
(6G4 ng/ml) as compared with untreated controls (84G
14 ng/ml; P!0.001). Osmotic pumps delivering 500 mg/day
ovine prolactin resulted in mean ovine prolactin levels of
353G81 ng/ml, measured at the time of pump removal.alling capability during the first hair
e Balb/c mice are shown. (A) Plasma
ioimmunoassay. (B) Relative expression of
ligand was assessed in dorsal skin by real
ribosomal 18S rRNA levels. Error bars
Journal of Endocrinology (2006) 191, 415–425
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regrowth first appeared in the axillary regions at 28.2G
0.2 days of age. This is 3 days earlier than axillary follicles of
untreated controls (31.1G0.2 days of age; P!0.01; Fig. 3).
When the implants were not inserted until 22 days of age, hair
regrowth (31.5G0.6 days of age) was similar to controls. A
similar trend was observed in the dorsal region. Mice
receiving BRC at 15 days of age had earlier hair regrowth
than controls (32.8G0.4 vs 36.0G0.4 days of age P!0.001),
but the age of hair emergence in the mice receiving BRC at
22 days was intermediate (33.5G0.5 days of age).Figure 3 Effects of varying prolactin treatments on hair follicle
cycling. The ages at which new hair first emerges are shown.
New hairs are seen initially in the axillary region and subsequently
in dorsal skin. Bromocriptine and prolactin treatment regimes are
summarised below the charts. The number of animals in each
treatment group is also shown. As compared with untreated
controls (Ctl), mice receiving bromocriptine (BRC) at 15 days of age
exhibited new hair emergence at a younger age in both body sites.
However, if BRC treatment did not commence until 22 days of age,
the advanced hair regrowth did not occur in the axilla. The age of
hair emergence when mice were treated with BRC at day 15 and
then received prolactin-releasing minipumps (500 mg per day) at
18, 22 or 26 days of age, lasting for 3 or 14 days duration is also
shown. Prolactin treatment for 3 days commencing at 18 days
abrogated the premature regrowth induced by earlier BRC
treatment. Prolactin (Prl) treatment for longer durations (14 days)
resulted in delayed hair regrowth. Error bars indicate S.E.M.
Treatment groups that are significantly different to either untreated
controls (Ctl) or to BRC administered at 15 days are indicated:
*P!0.05; †P!0.01; ‡P!0.001; ns, not significant.
Journal of Endocrinology (2006) 191, 415–425In the mice receiving exogenous prolactin as well as BRC,
hair regrowth was delayed in comparison with mice receiving
only BRC. Thus, in dorsal skin, the premature hair regrowth
in mice treated with BRC alone (at 32.8G0.4 days of age;
P!0.01) was reversed by the administration of prolactin for
3 days, commencing at 18 days of age (regrowth at 35G
0.1 days of age; P!0.05). Furthermore, if prolactin treatment
was extended to 14 days, dorsal hair cycles occurred later still
(39.5G0.5 days of age; P!0.01). Similarly, late dorsal
regrowth was observed if prolactin treatment commenced at
22 days of age (39.3G0.5 days of age; P!0.001), but not if
infusion commenced at 26 days (32.5G0.5 days of age). In
axillary skin, prolactin only reversed the effect of BRC if
treatment commenced at 15 days. Bearing in mind that hair
regrowth in the axilla normally precedes that in the dorsum,
these results indicate that prolactin only has an effect when
administered sufficiently early in telogen.
The effect of altered prolactin signalling was also investigated
by treatingmicewith domperidone,which increased circulating
prolactin to 142G30 ng/ml, compared with untreated control
levels of 89G8 ng/ml (P!0.01). The treatment between
18 and 30 days of age resulted in delayed hair cycles (37.3G
0.3 days of age) as compared with mice receiving the diluent
only (35.3G0.7 days of age; P!0.05). This result is evidence
that the altered hair cycling seen inmice treatedwith exogenous
prolactin was not an artefact caused by ovine prolactin exerting
non-physiological bioactivity in a murine host.
As the timing of prolactin treatments that affected hair
cycles coincided with weaning, we tested whether the age of
weaning influenced the onset of anagen. Mice weaned at
18 days underwent hair cycles at the same age as littermates
weaned at 24 days of age (dorsal hair emergence at 34.0G0.6
and 34.3G0.3 days of age respectively). This suggests that any
stress or hormonal changes associated with early weaning
were without measurable hair growth consequences.Grafting PRLR knockout skin onto scid host mice
To determine whether prolactin effects on hair cycling are
mediated by direct action of the hormone on hair follicles,
skin from PRLR knockout mice and wild-type littermates
was grafted onto immunodeficient hosts. Each host received
two grafts, one of knockout skin and another of wild-type
skin (Fig. 4A), allowing direct comparison of the two
genotypes in a normal endocrine setting. All the 20 pairs of
grafts were successfully established on scid mouse hosts. In
general, grafted mouse skin exhibited three anagen phases
over 15 weeks following transplantation, interspersed with
periods of telogen (Fig. 4B). Previous studies in our
laboratory have shown that the initial hair cycle is induced
by the surgical manipulation. It consistently occurs 10–
20 days after the grafting procedure and does not correspond
to normal hair cycle times in either hosts or donors. This
initial grafting-induced anagen is represented in Fig. 4B by
grey bars.www.endocrinology-journals.org
Figure 4 Hair growth in skin grafts from PRLR knockout (K/K) and wild-type (C/C) mice. (A) Scid mice carrying grafts from closely related
PRLR knockout (left scapular) and wild-type (right scapular) donor mice. Pigmented hair growing from the grafted skin is readily visible
against the white coat of the hosts. Representative males (a and b) and females (c and d) at the conclusion of the experiment, 89 days after
engraftment are shown. Hair is near to fully grown in mice a and c. Differences in hair growth between graft genotypes were revealed by
shaving the dorsal skin, including the graft sites, at 4-day intervals, as seen in mouse d. (B) All grafts exhibited a hair growth cycle at
18–20 days after surgery (grey bars). Subsequent cycles (black bars) in knockout grafts occurred in advance of sex matched wild-type grafts
(P!0.05). (C) Plasma prolactin concentration in donor PRLRK/K mice is grossly elevated as compared with PRLRC/C and scid recipients
(P!0.001). Error bars indicate S.E.M.
Prolactin and murine hair cycles . A J CRAVEN and others 421The PRLR genotype had no effect on the timing of the
grafting-induced hair cycle, but subsequent cycles were
advanced in knockout skin. Hair growth was also less well
synchronised within knockout grafts, and there was a marked
sex difference in cycle timing (Fig. 4B). The start of the
second growth period in knockout grafts preceded the wild
type by 5.9G1.9 days (P!0.01) in females and 3.4G1.8 days
(P!0.05) in males. For both sexes, the length of time that no
hair growth was observed was also lower in knockout
compared with wild-type grafts (Fig. 4B; P!0.05). Thus,
there was a shorter duration of telogen in the knockout aswww.endocrinology-journals.orgcompared with wild-type skin, even when both were exposed
to the same set of systemic factors. Circulating prolactin
concentrations in scid and wild-type 129Sv mice (i.e. the
PRLR knockout background) were similar, but both were
tenfold lower than seen in PRLR knockout (Fig. 4C).Discussion
The phenotype of PRLR knockout mice implicated
prolactin as an endocrine regulator of hair cycle timing. InJournal of Endocrinology (2006) 191, 415–425
Figure 5 Schematic representation of hair replacement patterns in
mouse skin with varying prolactin signalling capability. Progression
from their initial hair coat (shown as black mouse) to their subsequent
hair coat (shown as grey mouse). (A) Bromocriptine (BRC) treated
mice underwent hair cycles earlier than untreated controls, or those
also receiving prolactin (Prl) during telogen for 3 days. PRL-treatment
during early anagen had no effect while those BRC-treated mice
receiving PRL for 14 days had delayed hair growth beyond that
observed in controls. (B) Hair replacement in PRLRC/C and PRLR
K/K skin grafted onto immunodeficient scid mice. Hair cycles in
PRLRK/K explants occur earlier than PRLRC/C explants. However,
note that the difference in the duration of telogen appears greater
between entire PRLRK/K and PRLRC/C129Sv mice (Craven et al.
2001) than in their respective skin transplants onto scid mice.
A J CRAVEN and others . Prolactin and murine hair cycles422this study, we showed that changes in circulating prolactin
levels were associated with progression through the hair cycle
and with changes in prolactin signalling status in skin. Hair
follicle cycling in young Balb/c mice was synchronised, with
dorsal follicles entering catagen at 17–19 days of age and then
remaining in telogen until around day 26. In the same
animals, circulating prolactin was relatively low for the first 3
weeks after birth, in agreement with previous data (Barkley
1979), but began increasing from day 18. Thus, changes in
circulating prolactin are associated with the transition into
catagen, consistent with the possibility that prolactin has a
causal role in inhibiting hair growth. We confirmed this role
by showing that re-entry to anagen was advanced when
circulating prolactin secretion was suppressed with BRC, but
delayed when mice were treated with exogenous prolactin.
In unmanipulated mice, expression of the PRLR and
prolactin genes in skin also changed through the hair cycle,
but these changes occurred later than the changes in
circulating prolactin. Thus, expression levels were low during
telogen and early anagen but increased markedly by the 5th
week of age, in accordance with previous studies that also
report higher levels of PRLR transcripts during anagen
(Craven et al. 2001, Foitzik et al. 2003). The lagged response
of both full length and short form PRLR mRNAs in relation
to circulating prolactin may reflect ligand-mediated receptor
upregulation (Soboleva et al. 2005) as has been reported in a
number of organs including kidney, liver, mammary gland
(Barash et al. 1986) and adipose depots (Ling et al. 2000), as
well as skin (Nixon et al. 2002). Assuming protein translation
occurs, a functional role has yet to be ascribed for prolactin
synthesised within the integument, but maintenance of tonic
signalling during periods of low pituitary secretion has been
postulated (Ben-Jonathan et al. 1996). Overall, these results
suggest that the sensitivity of skin to systemic prolactin
changes throughout the hair cycle.
More generally, hair cycling is likely to be influenced by
prolactin signalling status within the skin as well as circulating
prolactin levels per se. The low prolactin signalling potential in
mouse pups, due to low concentrations of both circulating
ligand and cellular receptors, may underlie the brevity of the
first telogen phase. Subsequent telogen periods become
progressively longer (Ebling et al. 1991), against a background
of increasing prolactin and increasing PRLR expression.
The effects of both BRC and prolactin administration were
influenced by the time at which treatment commenced. BRC
affected hair regrowth on the axilla only at 15 days of age, but
on the dorsum at 15 and 22 days of age. Similarly, prolactin
administration starting at 18 and 22 days of age reversed the
effects of BRC on dorsal follicle cycling, but axillary follicles
were only affected by prolactin treatment from 18 days. These
dorso-ventral differences in response correspond to the
difference between body sites in the timing of the hair
growth wave. Thus, the period of sensitivity to altered
prolactin signalling appears to be directly related to the follicle
growth cycle, with only telogen follicles able to respond.
Once follicles enter early anagen, they exhibit a commitmentJournal of Endocrinology (2006) 191, 415–425to continued growth that cannot be altered by perturbing
prolactin signalling. Our results are diagrammatically sum-
marised in Fig. 5.
It is likely that follicles become resensitised to prolactin
later in anagen. Prolactin has been shown to inhibit the
growth of anagen follicles in mice (Foitzik et al. 2003) and in
sheep (Pearson et al. 1999). Prolactin is able to hasten catagen
in murine (Foitzik et al. 2003) and human (Foitzik et al. 2006)
skin organ culture. Hence, the inhibitory effect of prolactin
can be seen in species with both seasonal and non-seasonal
hair cycling patterns. Furthermore, prolactin is inhibitory at
different stages of the follicle cycle, with the ability to reduce
hair length (Craven et al. 2001) or shorten anagen, as
demonstrated in sheep, or to lengthen telogen as we have
demonstrated in Balb/c mice.
Hair regrowth affected by BRC was not as premature as
that observed in PRLR-gene disrupted mice (Craven et al.
2001). This difference might reflect residual prolactin due towww.endocrinology-journals.org
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which is not suppressed by BRC (Ben-Jonathan et al.
1996). It is also possible that a BRC-induced mechanism
unrelated to prolactin is acting to influence the induction of
anagen. For example, the pro-opiomelanocortin system (Paus
et al. 1999) may be upregulated via activation of BRC-
sensitive dopamine receptors (Farrell et al. 1992). However,
prolactin-negative effects of BRC on hair cycles were
consistent with other manipulations of prolactin.
Removal of prolactin through ablation of the pituitary
gland has been shown previously to advance hair cycles in rats
(Mohn 1958, Ebling et al. 1991). However, this effect was
attributed to the withdrawal of adrenal and gonadal steroids.
Advanced hair follicle activity is also stimulated by
hypophysectomy, gonadectomy, adrenalectomy and adminis-
tration of thyroxine (Ebling et al. 1991). In general, these
treatments need to be carried out well in advance of the
timing of expected hair eruption, which is also consistent
with sensitivity during telogen and some degree of follicle
growth autonomy after the initiation of anagen. Similarly,
glucocorticoid treatments can block follicle regrowth, but
only if applied prior to anagen induction (Stenn et al. 1993).
PRLR-deficient mice have grossly elevated levels of
circulating prolactin due to ablation of the feedback signalling
that regulates the pituitary lactotrophs (Grattan et al. 2001).
However, the regulation of other hormones is also perturbed
in these mice. For example, circulating concentrations of
oestradiol are lower in female knockout mice at oestrous
(37 pg/ml compared with 53 pg/ml in wild-type mice)
(Clement-Lacroix et al. 1999). Oestradiol has been shown to
have a direct inhibitory effect on hair growth cycles (Ebling
et al. 1991), and oestradiol receptors have been located in the
dermal papillae of telogen follicles (Oh & Smart 1996).
Similarly, PTH is increased (Clement-Lacroix et al. 1999) and
has been implicated previously in hair cycle regulation (Schilli
et al. 1997).
Thus, prior to this study, it was unclear whether prolactin
exerted its effect directly on the follicle or indirectly by
influencing alternative endocrine pathways (Craven et al.
2001). By transplanting skin lacking prolactin-signalling
capability to a normal endocrine environment, and observing
that a shorter telogen period is retained, we have
demonstrated that prolactin acts via a direct mode of action.
Although considerable variation in follicle behaviour
occurred, with respect to both follicles within and between
grafts, differences between genotypes and sexes were evident.
Variation in hair growth between males and females, even in
PRLR-deficient mice, may arise due to systemic differences
related to the sex of the host. Furthermore, these
transplantation experiments do not exclude the possibility
that indirect effects of PRLR ablation exert an additional
intra-cutaneous influence on follicle cycling. However, the
results demonstrate a skin-autonomous effect, and given
the strong localisation of PRLR and PRLR mRNA in the
outer root sheath and secondary hair germ of hair follicleswww.endocrinology-journals.org(Craven et al. 2001, Foitzik et al. 2003), it is reasonable to
conclude that prolactin acts directly on the follicle.
In contrast to suppressive effects of oestradiol (Oh & Smart
1996, Chanda et al. 2000), glucocorticoids (Stenn et al. 1993)
and ACTH (Ebling et al. 1991), the immunosuppressant drug
cyclosporin A (CsA) is a known hair growth stimulant that
can induce telogen follicles into anagen prematurely (Paus
et al. 1989, Maurer et al. 1997). Although the mechanism of
its action within the hair follicle is unclear, CsA is known to
complex with cyclophillins, which interact directly with the
PRLR and its signal transduction factors. These molecules
have propyl isomerase activity that induces structural changes
within the PRLR intracellular domain and, along with
further interactions with JAK2 (cyclophillin A) (Syed et al.
2003) and Stat5 and protein inhibitor of activated stat (PIAS)
(cyclophillin B) (Rycyzyn & Clevenger 2002), are able to
potentiate prolactin-induced gene transcription. Therefore,
follicle stimulatory actions of CsA, which possibly arise from
decreased PRLR signal transduction, are consistent with the
inhibitory nature of prolactin reported here.
At the cellular level, the function of prolactin within the
follicle remains unclear. Different mammalian cells are known
to exhibit a variety of responses to prolactin stimulation,
including changes in cell proliferation, migration and
apoptosis (Bole-Feysot et al. 1998, Clevenger et al. 2003).
In follicles, PRLR have been localised to keratinocytes in the
middle of the follicle outer root sheath (Craven et al. 2001,
Nixon et al. 2002, Foitzik et al. 2003), up to and including the
bulge region. The bulge region is thought to contain a
reservoir of stem cells, the daughters of which migrate down
the outer root sheath to repopulate the rapidly proliferating
germinal matrix in the lower follicle (Oshima et al. 2001,
Stenn & Paus 2001). Germinal matrix cells then differentiate
to form the hair shaft. Catagen is thought to be induced, at
least in part, by the loss of proliferative activity in the germinal
matrix. We therefore speculate that prolactin may exert its
effects on follicle cycling by modulating the migration of
precursor cells in the outer root sheath. This could be
achieved by regulating cell adhesion factors such as the
cadherins (Sultan et al. 2005) or by Stat3-responsive factors
(Kira et al. 2002), both of which are necessary for continuous
hair cycling (Sano et al. 1999, Young et al. 2003). Such
inhibition of migration would deprive the germinal matrix of
cells with proliferative potential, thereby either extending the
telogen phase or terminating anagen.
In summary, we have demonstrated that prolactin acts
directly within the skin to modulate the timing and duration
of telogen. Follicles are responsive to prolactin signalling only
during some phases of the growth cycle. This point has
implications for the design of experiments involving prolactin
and hair growth, and may explain the failure of some previous
attempts to alter hair cycles by increasing circulating prolactin.
The influence of prolactin on human follicle growth is
becoming increasingly recognised (Orfanos & Hertel 1988,
Paus 1991, Krause et al. 2000, Alonso & Rosenfield 2003,
Foitzik et al. 2006). The results of our experiments suggestJournal of Endocrinology (2006) 191, 415–425
A J CRAVEN and others . Prolactin and murine hair cycles424the potential for new strategies to address human hair growth
disorders involving perturbed follicle cycling, including
telogen effluvium and hirsutism (Orfanos & Hertel 1988).Acknowledgements
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